These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11738839)

  • 21. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
    Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression.
    Makedonski K; Abuhatzira L; Kaufman Y; Razin A; Shemer R
    Hum Mol Genet; 2005 Apr; 14(8):1049-58. PubMed ID: 15757975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
    Wan M; Zhao K; Lee SS; Francke U
    Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease.
    Villard L; Lévy N; Xiang F; Kpebe A; Labelle V; Chevillard C; Zhang Z; Schwartz CE; Tardieu M; Chelly J; Anvret M; Fontès M
    J Med Genet; 2001 Jul; 38(7):435-42. PubMed ID: 11432961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
    Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
    Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MECP2 and beyond: phenotype-genotype correlations in Rett syndrome.
    Christodoulou J; Weaving LS
    J Child Neurol; 2003 Oct; 18(10):669-74. PubMed ID: 14649547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Shahbazian MD; Zoghbi HY
    Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rett syndrome: clinical correlates of the newly discovered gene.
    Percy AK
    Brain Dev; 2001 Dec; 23 Suppl 1():S202-5. PubMed ID: 11738873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo.
    Kumar A; Kamboj S; Malone BM; Kudo S; Twiss JL; Czymmek KJ; LaSalle JM; Schanen NC
    J Cell Sci; 2008 Apr; 121(Pt 7):1128-37. PubMed ID: 18334558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional consequences of Rett syndrome mutations on human MeCP2.
    Yusufzai TM; Wolffe AP
    Nucleic Acids Res; 2000 Nov; 28(21):4172-9. PubMed ID: 11058114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of X-chromosome inactivation in the manifestation of Rett syndrome.
    Takagi N
    Brain Dev; 2001 Dec; 23 Suppl 1():S182-5. PubMed ID: 11738869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
    Ohki I; Shimotake N; Fujita N; Jee J; Ikegami T; Nakao M; Shirakawa M
    Cell; 2001 May; 105(4):487-97. PubMed ID: 11371345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA; Goddard CJ; Thomas JO; Surani MA
    Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of Rett syndrome in child neurology.
    Dunn HG
    Brain Dev; 2001 Dec; 23 Suppl 1():S38-43. PubMed ID: 11738840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Another patient with MECP2 mutation without classic Rett syndrome phenotype.
    Milani D; Pantaleoni C; D'Arrigo S; Selicorni A; Riva D
    Pediatr Neurol; 2005 May; 32(5):355-7. PubMed ID: 15866439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of Rett syndrome from Ukraine--clinical diagnosis confirmed by mutation analysis of the MECP2 gene.
    Bzduch V; Zahorakova D; Grechanina E; Zdibskaja EP; Goldfarb IG; Zeman J; Martasek P
    Bratisl Lek Listy; 2004; 105(9):299-302. PubMed ID: 15633890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions.
    Laccone F; Huppke P; Hanefeld F; Meins M
    Hum Mutat; 2001 Mar; 17(3):183-90. PubMed ID: 11241840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
    Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
    Balmer D; Arredondo J; Samaco RC; LaSalle JM
    Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.